Why Piperacillina Sodica + Tazobactam is in shortage
unexpected increases in demand — e.g. “Elevata richiesta” (Italy)
causes not stated by the regulator
— e.g. “Motivi commerciali (carenza relativa solo al canale ospedaliero)” (Italy)
manufacturing problems — e.g. “Problemi produttivi” (Italy)
Recent shortage history
Italy: resolved 20 Apr 2026 (began 20 Apr 2026)
Italy: resolved 1 Oct 2025 (began 1 Oct 2025)
Italy: resolved 2 Jul 2025 (began 2 Jul 2025)
Italy: resolved 30 Apr 2024 (began 30 Apr 2024)
Italy: resolved 20 Jun 2023 (began 20 Jun 2023)
Italy: resolved 30 May 2023 (began 30 May 2023)
Italy: resolved 28 Aug 2018 (began 28 Aug 2018)
Italy: resolved 8 Feb 2018 (began 8 Feb 2018)
Frequently asked questions
Is Piperacillina Sodica + Tazobactam currently in shortage?
Yes. As of the latest regulator updates, Piperacillina Sodica + Tazobactam has 5 active shortage notices across 1 country (Italy). Status is refreshed daily from official regulatory sources.
Why is Piperacillina Sodica + Tazobactam in shortage?
Regulators attribute the current Piperacillina Sodica + Tazobactam shortages to unexpected increases in demand, causes not stated by the regulator, manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Piperacillina Sodica + Tazobactam shortage be resolved?
Regulator-estimated resolution dates currently range from 31 Oct 2026 to 31 Oct 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Piperacillina Sodica + Tazobactam shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Piperacillina Sodica + Tazobactam status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.